Latest On-Demand Webinars & Online Events

An incredible opportunity to ask Professor Boris Heifets anything about the world of Psychedelics.

New for 2023, this online event will provide researchers with an opportunity to learn about how spatial biology is helping us to gain a deeper understanding of molecular biology and mechanisms of disease. Speakers will discuss advances in spatial technologies and how they are being applied to provide a more complete picture of cells and complex biological systems in areas such as cancer research and neuroscience.

This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.

We are thrilled to present an exclusive AMA featuring the distinguished Professor Mark Lawler, PhD, FRCPath.

Cancer cells engage in intricate interactions with neighboring cancerous and stromal cells through direct cell-to-cell contact and paracrine signaling. Long-range communication with distant organ sites is facilitated by extracellular vesicles, as well as signaling molecules like cytokines, hormones and growth factors .

In this webinar, you will learn about the OGM workflow and how it can be applied to cell and gene therapy R&D, with emphasis on how it can significantly improve the quality, safety and overall risk profile of next-generation therapies.

Antibodies are ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have enabled drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies.

Natural killer (NK) cells are a promising tool in the fight against cancer. Engineering them with chimeric antigen receptors (CARs) further bolsters their specific anti-tumor activity.

This webinar describes how a new platform for high-throughput proteomics was used to identify multiple proteins associated with ovarian cancer. A 22-protein model was derived that discriminates ovarian cancer cases from benign controls with high accuracy.